医薬品有効成分(API)の世界市場規模及び予測:合成別(バイオ技術、合成)、メーカー種類別(キャプティブ、マーチャント)、種類別(一般、革新的)、用途別、動向分析 2014-2025...市場調査レポートについてご紹介

【英文タイトル】Active Pharmaceutical Ingredients (API) Market Size And Forecast By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Type (Generic, Innovative), By Application And Trend Analysis, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR’s internal database
1.2 Research Methodology
1.3 Geographic scope & assumptions
1.4 Region-wise market calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based segment share calculation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 API Market Variables, Trends & Scope
3.1 Market segmentation & scope
3.1.1 Market Driver Analysis
3.1.1.1 Growing geriatric population base
3.1.1.2 Growing prevalence of target diseases such as hospital acquired infections, genetic, cardiovascular and neurological diseases
3.1.1.3 Increasing preference for targeted therapy approach in cancer treatment
3.1.1.4 Increasing preference for outsourcing APIs
3.1.2 Market restraint analysis
3.1.2.1 Large capital investments and production cost
3.1.3 Stringent safety and handling regulations regarding APIs
3.2 Penetration & growth prospect mapping
3.3 Active Pharmaceutical Ingredient – SWOT Analysis, By Factor (political & legal, economic and technological)
3.4 Industry Analysis – Porter’s
Chapter 4 API Market: Type of Synthesis Estimates & Trend Analysis
4.1 Active pharmaceutical ingredient market: Type of synthesis movement analysis
4.2 Biotech
4.2.1 Biotech market, 2014 – 2025 (USD Billion)
4.2.2 Monoclonal Antibodies
4.2.3 Monoclonal Antibodies market, 2014 – 2025 (USD Billion)
4.2.4 Recombinant proteins
4.2.5 Recombinant proteins market, 2014 – 2025 (USD Billion)
4.2.6 Vaccines
4.2.7 Vaccines market, 2014 – 2025 (USD Billion)
4.3 Synthetic
4.3.1 Synthetic market, 2014 – 2025 (USD Billion)
Chapter 5 API Market: Type of Manufacturer Estimates & Trend Analysis
5.1 Active pharmaceutical ingredient market: Type of Manufacturer movement analysis
5.2 Captive APIs
5.2.1 Captive APIs market, 2014 – 2025 (USD Billion)
5.3 Merchant APIs
5.3.1 Merchant APIs market, 2014 – 2025 (USD Billion)
Chapter 6 API Market: Type Estimates & Trend Analysis
6.1 Active pharmaceutical ingredient market: Type movement analysis
6.2 Generic APIs
6.2.1 Generic APIs market, 2014 – 2025 (USD Billion)
6.3 Innovative APIs
6.3.1 Innovative APIs market, 2014 – 2025 (USD Billion)
Chapter 7 API Market: Application Estimates & Trend Analysis
7.1 Active pharmaceutical ingredient market: Application movement analysis
7.2 Cardiovascular Disease
7.2.1 Cardiovascular Disease market, 2014 – 2025 (USD Billion)
7.3 Oncology
7.3.1 Oncology market, 2014 – 2025 (USD Billion)
7.4 CNS and Neurological Disorders
7.4.1 CNS and Neurological Disorders market, 2014 – 2025 (USD Billion)
7.5 Orthopedic Disorders
7.5.1 Orthopedic Disorders market, 2014 – 2025 (USD Billion)
7.6 Endocrinology
7.6.1 Endocrinology market, 2014 – 2025 (USD Billion)
7.7 Pulmonology
7.7.1 Pulmonology market, 2014 – 2025 (USD Billion)
7.8 Gastrointestinal Disorders
7.8.1 Gastrointestinal Disorders market, 2014 – 2025 (USD Billion)
7.9 Nephrology
7.9.1 Nephrology market, 2014 – 2025 (USD Billion)
7.10 Ophthalmology
7.10.1 Ophthalmology market, 2014 – 2025 (USD Billion)
7.10.2 Others market, 2014 – 2025 (USD Billion)
Chapter 8 API Market: Regional Estimates & Trend Analysis
8.1 Active pharmaceutical ingredient market share, by region, 2015 & 2025
8.2 North America
8.2.1 North America active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.2.2 U.S
8.2.2.1 U.S active pharmaceutical Ingredient market, 2014 – 2025 (USD Billion)
8.2.3 Canada
8.2.3.1 Canada active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3 Europe
8.3.1 Europe active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3.2 UK
8.3.2.1 UK active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.3.3 Germany
8.3.3.1 Germany active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4 Asia Pacific
8.4.1 Asia Pacific active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.2 Japan
8.4.2.1 Japan active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.3 China
8.4.3.1 China active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.4.4 India
8.4.4.1 India active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5 Latin America
8.5.1 Latin America active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5.2 Brazil
8.5.2.1 Brazil active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.5.3 Mexico
8.5.3.1 Mexico active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.6 MEA
8.6.1 MEA active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
8.6.2 South Africa
8.6.2.1 South Africa active pharmaceutical ingredient market, 2014 – 2025 (USD Billion)
Chapter 9 Competitive Landscape
9.1 Strategy Framework
9.2 Market Participation Categorization
9.3 Company Profiles
9.3.1 AbbVie, Inc.
9.3.1.1 Company overview
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 Boehringer Ingelheim GmbH
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Bristol-Myers Squibb Company
9.3.3.1 Company overview
9.3.3.2 Financial performance
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 Cipla, Inc.
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 Merck& Co., Inc.
9.3.5.1 Company overview
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Albemarle Corporation
9.3.6.1 Company overview
9.3.6.2 Financial overview
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Aurobindo Pharma
9.3.7.1 Company overview
9.3.7.2 Financial overview
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 Mylan N.V.
9.3.8.1 Company overview
9.3.8.2 Financial overview
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Teva Active Pharmaceuticals Industries Ltd.
9.3.9.1 Company overview
9.3.9.2 Financial overview
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Sun Pharmaceutical Industries, Ltd.
9.3.10.1 Company overview
9.3.10.2 Financial overview
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 Dr. Reddy’s Laboratories Ltd
9.3.11.1 Company overview
9.3.11.2 Financial overview
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives


【レポート販売概要】

■ タイトル:医薬品有効成分(API)の世界市場規模及び予測:合成別(バイオ技術、合成)、メーカー種類別(キャプティブ、マーチャント)、種類別(一般、革新的)、用途別、動向分析 2014-2025
■ 英文:Active Pharmaceutical Ingredients (API) Market Size And Forecast By Type of Synthesis (Biotech, Synthetic), By Type of Manufacturer (Captive, Merchant), By Type (Generic, Innovative), By Application And Trend Analysis, 2014-2025
■ 発行日:2017年1月2日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707013
■ 調査対象地域:グローバル
  • Exploration and Production KazMunaiGas:石油・ガスの開発・生産動向及びコスト分析- 2012
    Exploration and Production KazMunaiGas Oil & Gas Exploration and Production Operations and Cost Analysis - 2012 Summary Exploration and Production KazMunaiGas Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The …
  • 世界の対IED防衛市場動向2013-2023:主な開発プロジェクト
    This report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Counter IED. The report offers detailed information regarding quantity procured, country/companies supplying the equipment, delivery period and total contract value.
  • 心不整脈治療法の世界市場2019-2023
    Global Cardiac Arrhythmias Therapeutics Market: About this market Cardiac arrhythmias therapeutics are pharmaceutical agents that are used to normalize the issue of cardiac arrhythmia. Technavio’s cardiac arrhythmias therapeutics market analysis considers sales from both oral and intravenous applications. Our analysis also considers the sales of cardiac arrhythmias therapeutics in North America, E …
  • 静電気防止フィルムの世界市場2019-2023
    Global Anti-Static Films Market: About this market Anti-static films are a type of plastic films that provide a decay of static charge to prevent accumulations, which can lead to the discharge or initiation of other nearby electrical events. Technavio’s anti-static films market analysis considers sales from both the segments including rigid and flexible anti-static films. Our analysis also conside …
  • 世界の糖尿病性足部潰瘍治療薬市場
    OpportunityAnalyzer: Diabetic Foot Ulcers - Opportunity Analysis And Forecasts To 2017 - Event-Driven Update Summary Diabetic foot ulcers (DFUs) are a common complication of diabetes, and with the increasing prevalence of diabetes across all markets, the number of patients suffering from DFUs is also expected to rise. Despite the availability of various treatment modalities, there are currently fe …
  • Ciclopirox (Dermatophytic Onychomycosis):市場予測と分析(~2022)
    Ciclopirox (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Ciclopirox (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022”. Dermatophytic onychomycosis (DO) is characterized as being a fungal infection of the nail. Infection can involve the nail unit (nail matrix, nail bed, or nail pl …
  • 石膏、無水石膏の国際貿易動向
    This report examines international trade and worldwide market trends pertaining to gypsum, anhydrite. The report will be of considerable interest primarily to relevant strategic planners, senior company officials and importers/exporters, since it features invaluable information on gypsum, anhydrite export/import operations segmented by country and region. The report covers the 2007-2012 period, wi …
  • グローバル医療デバイス産業サーベイ(2013-2014):市場動向、購買戦略
    Why was the report written? This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading global medical devices industry executives; it provides data and analysis on buyer expenditure, procurement, and developments within the global medical devices industry. It includes key topics such as global medical devices industry buyer expenditure and procurement beh …
  • 柔軟剤の世界市場2017-2021
    About Fabric Conditioner Fabric conditioner is a constituent added to clothes during the washing process to make them softer and more durable. The chemicals in these products also remove stains and prevent the fabric from developing static electricity, extending the life of the garment. A fabric conditioner functions by depositing a lubricating chemical on the fabric, which imparts it softness, re …
  • アトピー性皮膚炎治療薬の世界市場予測および分析(~2024)
    PharmaPoint: Atopic Dermatitis - Global Drug Forecast and Market Analysis to 2024 Summary Although the past decade has seen the atopic dermatitis market remain relatively unchanged and a saturated, highly genericized arena, the coming decade could see the launch of the first biologic, which will set a precedent and pave the way for others to follow suit. By the mid-to-late term of GlobalData’s 201 …
  • 硬質プラスチック:世界市場動向2011-2016(Rigid Plastics – A Global Market Watch, 2011 – 2016)
    Global Market Watch: The rigid plastics market is expected to reach US$272.9 billion worth by 2016 primarily supported by the segments: types - caps & closures and pails and resins ? Polyethylene Tetraphthalate (PET) and Poly Vinyl Chloride (PVC). Globally, Polyethylene (PE) and Polypropylene (PP) together account for approximately 46% of the market are expected to support the plastics industry go …
  • 胃部・食道胃接合部腺癌市場:アメリカの治療薬市場
    Gastric and Gastroesophageal Junction Adenocarcinoma - US Drug Forecast and Market Analysis to 2024 Summary Gastric and gastroesophageal junction adenocarcinoma (G/GEJAC) represents the majority of gastric cancer cases worldwide. It is the fifth most diagnosed cancer globally, and the third most common cause of cancer death in the world. The major treatments for G/GEJAC are chemotherapy-based, but …
  • 自動車触媒コンバーターの世界市場2018-2022
    108 pages, November 2018 About this market Globally, approximately 90% of the passenger vehicles are equipped with catalytic converters. The global automotive industry registered sales of 70.85 million units of passenger vehicles in 2017, with a growth rate of 1.93% compared with 2016. In terms of geography, APAC dominated the global passenger vehicles sales with approximately 40.74 million units, …
  • 臨床アラーム管理の世界市場予測(~2023年)
    The clinical alarm management market is projected to grow at a CAGR of 30.4% during the forecast period.The global clinical alarm management market is expected to reach 1,724 million by 2023 from an estimated USD 457 million in 2018, at a CAGR of 30.4% during the forecast period. Increasing alarm fatigue, high prevalence of chronic diseases, growth in the geriatric population, need for cost-contai …
  • TransAtlantic Petroleum Ltd.:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    TransAtlantic Petroleum Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary TransAtlantic Petroleum Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。